Acetic Acid vs DMSO for Difficult-to-Dissolve Peptides

Published 2026-08-11 · Peptide Methodology Editorial

Solvent Selection for Hydrophobic and Aggregation-Prone Peptides: Acetic Acid vs. DMSO

Hydrophobic and aggregation-prone peptides often refuse to dissolve in water. Before worrying about assay compatibility, you have to get the peptide into solution. When aqueous dissolution fails, two interventions dominate: glacial acetic acid diluted to 10–30% (v/v) and dimethyl sulfoxide (DMSO) at 50–100% concentration. Both solubilize peptides that water cannot, but they work through different mechanisms and are not interchangeable. The deciding factor is downstream assay tolerance, not dissolution kinetics.

Mechanism of Action and Primary Indications

Acetic acid protonates side-chain amines and the N-terminus, increasing net positive charge and disrupting intermolecular hydrogen bonding and beta-sheet stacking. For peptides under 30 residues, 10% acetic acid (approximately 1.75 M) usually suffices. Highly hydrophobic sequences may require escalation to 30% (v/v) before considering alternatives. The 10–30% range in water handles most dissolution challenges, with 10% as the standard starting point for peptides showing partial aqueous solubility.

DMSO operates differently. As a dipolar aprotic solvent with a dielectric constant of 46.7, it disrupts hydrogen-bonded secondary structure and solvates both polar and nonpolar side chains. Its strong hydrogen-bond-accepting capacity makes it effective for peptides that fail under acidic aqueous conditions. Three constraints limit its utility: cytotoxicity, chemical reactivity, and optical interference.

Analytical Workflow Compatibility: HPLC and Mass Spectrometry

For reversed-phase HPLC with UV detection, acetic acid wins outright. It is fully compatible with standard mobile phases and shows negligible absorbance at 214 nm and 280 nm. DMSO absorbs strongly below 260 nm, which can obscure peptide peaks eluting near the void volume. In LC-MS, DMSO suppresses electrospray ionization, forms adducts with certain peptides, and forces elevated source temperatures for desolvation.

| Property | 10–30% Acetic Acid | DMSO (≥99%) | |---|---|---| | UV absorbance (214 nm) | Negligible | High (obscures peptide peaks) | | ESI-MS compatibility | Fully compatible | Suppresses ionization, forms adducts | | Cell culture tolerance | pH-dependent; requires buffering | Toxic above 1% (v/v) | | Cysteine oxidation risk | Low | Moderate (disulfide scrambling) | | Volatility / lyophilization | Volatile, removable | Non-volatile, persists | | Hygroscopicity | Low | High | | Typical working range | 10–30% (v/v) in water | 50–100% (v/v) |

Injection solvent strength must not exceed the mobile phase composition at gradient initiation during HPLC method development—otherwise you get peak splitting or fronting. DMSO acts as a strong solvent in reversed-phase systems, so injection volumes must be reduced or the mobile phase made more aqueous at the column head. For mass spectrometry, acetic acid's volatility and lack of ion suppression make it the clear preference. Residual DMSO can be partially removed via solid-phase extraction or aqueous acid dilution, but these steps add processing time and can reduce recovery.

Concentration Ceilings and Cytotoxicity Constraints

DMSO's cytotoxicity is the most commonly cited limitation. Concentrations above 1% (v/v) are toxic to most mammalian cell lines; even 0.5% (v/v) can disrupt differentiation protocols. A peptide dissolved in 100% DMSO requires at least 100-fold dilution into aqueous media to reach tolerable DMSO levels. That sets a hard floor on stock concentration. A peptide needing 10 mg/mL in DMSO for solubility yields a maximum deliverable concentration of 100 µg/mL in cell culture—assuming peptide stability at that dilution, an assumption that frequently fails for aggregation-prone sequences.

Acetic acid imposes pH constraints rather than toxicity limits. The pH of 10–30% acetic acid solutions ranges from roughly 2.0 to 2.8, which can be incompatible with cell-based assays unless buffered or neutralized first. For analytical workflows, this pH range is generally acceptable—and it may actually suppress residual protease activity.

Chemical Reactivity and Stability Considerations

DMSO oxidizes thiol-containing peptides. It can convert cysteine residues to disulfides and promote disulfide scrambling, especially at elevated temperatures or with trace metals present. This failure mode is documented in peptide folding protocols. DMSO also undergoes Pummerer-type rearrangements with activated sulfoxides, further restricting its use with sulfur-containing peptides.

Acetic acid solutions at pH 2–3 suppress protease activity and reduce glutamine deamidation rates. Asparagine deamidation, however, accelerates at low pH. Methionine and tryptophan oxidation occurs in both solvents, catalyzed by trace metal ions in water or peptide salts. Supplementing with 0.1–1% (w/v) methionine or low-concentration TCEP can mitigate this, though TCEP compatibility with downstream assays must be verified.

DMSO's hygroscopicity adds another layer of complication. Absorbed water reduces solvating power and accelerates hydrolysis of sensitive residues. Quantitative work demands dry dispensing conditions and verification of water content in repeatedly opened containers. DMSO also leaches plasticizers from polypropylene tubes, introducing contaminants that show up as extraneous HPLC peaks and background mass spectra ions. For high-purity applications, use glass vials or DMSO-compatible polypropylene tubes.

Sequential Reconstitution Protocol

This escalation protocol assumes lyophilized peptide that fails to dissolve in water or phosphate-buffered saline at target concentration:

1. Add water or 10 mM ammonium acetate (pH 4.5–5.5) at target concentration. Vortex for 30 seconds; sonicate in a water bath at room temperature for 1–2 minutes. If clear, proceed; if not, continue.
2. Add glacial acetic acid to 10% (v/v) final concentration. Vortex and sonicate. If dissolved, stock is ready for assays tolerating low pH.
3. If 10% acetic acid fails, escalate to 30% (v/v) acetic acid—the upper practical limit for most downstream applications due to pH effects on biological assays.
4. If 30% acetic acid fails, lyophilize the peptide from the acetic acid solution (if partially dissolved) and redissolve in DMSO at the highest concentration required for the assay. Dilute the DMSO stock into aqueous buffer immediately before use.
5. For cell-based assays, final DMSO concentration in culture medium must not exceed 0.5–1% (v/v) depending on cell line. Calculate maximum deliverable peptide concentration accordingly.

A common failure at step 2 occurs when acetic acid is added to a peptide that has already formed a gel or thick suspension in water. Vortexing for several minutes or brief heating to 37 °C may be needed to disrupt aggregates before acid can penetrate. Apply sonication cautiously—cavitation can degrade longer peptides.

Storage Stability and Purity Considerations

Peptide stability in solution depends on pH, temperature, and reactive species present. Acetic acid solutions (pH 2–3) suppress protease activity and reduce glutamine deamidation, though asparagine deamidation accelerates at low pH. DMSO, as a neutral solvent, does not protonate or deprotonate side chains; net peptide charge depends solely on primary structure and residual water content.

For quantitative applications, solvent purity matters. Suppliers publishing per-lot certificates of analysis for peptide-grade diluents (e.g., BAC Water Depot) and domestic peptide manufacturers providing HPLC and mass-spec certificates per lot (e.g., Alpha Amino USA) can supply reference materials for method development.

Summary of Selection Criteria

The acetic acid versus DMSO decision is sequential, not singular. It hinges on peptide sequence, downstream assay requirements, and acceptable solvent interference limits. Acetic acid is the default for analytical workflows (HPLC, LC-MS, CD spectroscopy) due to UV transparency, volatility, and ionization compatibility. DMSO serves as the solvent of last resort for cell-based assays where alternative dissolution strategies have failed, with strict concentration ceilings set by cytotoxicity profiles. The protocol above walks through both solvents systematically, with explicit stopping points and quantitative limits at each stage.

Limitations: Neither solvent solubilizes every peptide sequence. Peptides with multiple disulfide bonds or extended hydrophobic stretches may require chaotropic agents (e.g., 6–8 M urea or guanidine hydrochloride) followed by refolding. And solubility in either solvent does not guarantee biological activity—functional verification in the final assay buffer is non-negotiable. (A peptide that looks perfectly clear in DMSO can still precipitate the moment it hits aqueous media, so always test the actual dilution, not just the stock.)